Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IPI Legacy Liquidation CoIMPL · Entity 15659 | CFO | May 10, 2023 | May 12, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IPI Legacy Liquidation Co
Report date May 10, 2023 · Filed May 12, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.43 · Expires 2033-05-10 | Direct | 175,000 |
Reported balance
After 2023-05-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-05-10 · Grant · Acquired 175,000 · Balance 175,000 F1: The option vests as to 25% of the total shares on May 10, 2024 and then 1/48th of the total shares vests on each monthly anniversary thereafter, subject to the reporting person's provision of service to the issuer on each vesting date. |
| Restricted Stock Units (RSUs)SEC Table II · derivative / convertible security · Expires 2033-05-10 | Direct | 47,500 |
Reported balance
After 2023-05-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-05-10 · Grant · Acquired 47,500 · Balance 47,500 F2: Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F3: The RSUs vest as to 100% of the total shares on May 31, 2024, subject to the reporting person's continuation of employment on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests as to 25% of the total shares on May 10, 2024 and then 1/48th of the total shares vests on each monthly anniversary thereafter, subject to the reporting person's provision of service to the issuer on each vesting date.
F2: Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
F3: The RSUs vest as to 100% of the total shares on May 31, 2024, subject to the reporting person's continuation of employment on such vesting date.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AMARIN CORP PLC\UK
Report date July 29, 2022 · Filed August 03, 2022
Section 16 reporting ended · disclosed 2022-08-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 301,882 |
Reported balance
After 2022-07-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-07-29 · Exercise / conversion · Acquired 47,767 · Balance 301,882 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2: On August 2, 2021, the Reporting Person was granted 143,300 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "2020 Plan"). These RSUs vest in three equal installments on each of July 31, 2022, July 31, 2023 and July 31, 2024. As the first vesting date fell on a weekend, the first vesting event occurred on July 29, 2022, the previous business day. F3: Not applicable. F4: Includes 3,368 shares purchased under the Issuer's 2017 Employee Stock Purchase Plan on May 31, 2022. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 284,662 |
Reported balance
After 2022-07-29 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2022-07-29 · Tax withholding · Disposed 17,220 · Balance 284,662 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 337,314 |
Reported balance
After 2022-08-01 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2022-08-01 · Tax withholding · Disposed 29,682 · Balance 337,314 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. F6: Reflects the effect of certain non-reportable transactions occurring following the Reporting Person's separation of service with the Issuer. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 95,533 |
Reported balance
After 2022-07-29 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-07-29 · Exercise / conversion · Disposed 47,767 · Balance 95,533 F7: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2: On August 2, 2021, the Reporting Person was granted 143,300 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "2020 Plan"). These RSUs vest in three equal installments on each of July 31, 2022, July 31, 2023 and July 31, 2024. As the first vesting date fell on a weekend, the first vesting event occurred on July 29, 2022, the previous business day. F3: Not applicable. F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
Filing footnotes · ownership attribution and instrument terms
F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2: On August 2, 2021, the Reporting Person was granted 143,300 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2020 Stock Incentive Plan (the "2020 Plan"). These RSUs vest in three equal installments on each of July 31, 2022, July 31, 2023 and July 31, 2024. As the first vesting date fell on a weekend, the first vesting event occurred on July 29, 2022, the previous business day.
F3: Not applicable.
F4: Includes 3,368 shares purchased under the Issuer's 2017 Employee Stock Purchase Plan on May 31, 2022.
F5: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
F6: Reflects the effect of certain non-reportable transactions occurring following the Reporting Person's separation of service with the Issuer.
F7: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.
CATALYST PHARMACEUTICALS, INC.
Report date July 15, 2026 · Filed July 17, 2026
Section 16 reporting ended · disclosed 2026-07-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.001 per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Disposition to issuer · Disposed 13,665 · Balance 0 F1: The reported securities were disposed of in connection with the consummation of the acquisition of the Issuer by Angelini Pharma S.p.A. (the "Merger") |
| Options to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $16.81 · Expires 2031-01-01 | Direct | 0 |
Reported balance
After 2026-07-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-15 · Disposition to issuer · Disposed 257,214 · Balance 0 F3: In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. F5: Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
| Options to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $21.12 · Expires 2031-11-21 | Direct | 0 |
Reported balance
After 2026-07-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-07-15 · Disposition to issuer · Disposed 169,248 · Balance 0 F3: In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. F5: Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
| Options to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $22.77 · Expires 2032-11-20 | Direct | 0 |
Reported balance
After 2026-07-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-07-15 · Disposition to issuer · Disposed 131,536 · Balance 0 F3: In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option. F5: Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2029-01-01 | Direct | 0 |
Reported balance
After 2026-07-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-07-15 · Disposition to issuer · Disposed 21,416 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4: In connection with the consummation of the Merger, each reported restricted stock unit ("RSU") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU. F5: Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2027-11-21 | Direct | 0 |
Reported balance
After 2026-07-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-07-15 · Disposition to issuer · Disposed 13,788 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4: In connection with the consummation of the Merger, each reported restricted stock unit ("RSU") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU. F5: Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2028-11-20 | Direct | 0 |
Reported balance
After 2026-07-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-07-15 · Disposition to issuer · Disposed 39,701 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4: In connection with the consummation of the Merger, each reported restricted stock unit ("RSU") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU. F5: Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities were disposed of in connection with the consummation of the acquisition of the Issuer by Angelini Pharma S.p.A. (the "Merger")
F2: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3: In connection with the consummation of the Merger, each reported stock option ("Option") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option.
F4: In connection with the consummation of the Merger, each reported restricted stock unit ("RSU") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU.
F5: Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger.
CinCor Pharma, Inc.
Report date February 24, 2023 · Filed February 24, 2023
Section 16 reporting ended · disclosed 2023-02-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-02-24 transaction · row 1
1 source rowRow 1 · 2023-02-24 · Disposition to issuer · Disposed 202,437 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of January 8, 2023, by and among CinCor Pharma, Inc. (the "Issuer"), AstraZeneca Finance and Holdings Inc. ("Parent") and Cinnamon Acquisition, Inc., a wholly owned subsidiary of Parent ("Purchaser"), on February 24, 2023, Purchaser completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"). F2: This line item represents restricted stock units ("RSUs") held by the Reporting Person at the effective time of the Merger, pursuant to the Merger Agreement, except as otherwise set forth in the Merger Agreement, each outstanding RSU was accelerated and became fully vested and was cancelled and automatically converted into the right to receive, without interest, (i) cash in an amount equal to (a) the total number of Shares issuable in settlement of such RSU immediately prior to the effective time of the Merger multiplied by (b) $26.00 per share (the "Cash Amount"), and (ii) one contingent value right ("CVR") per Share issuable in settlement of such RSU, representing the right to receive a contingent payment of $10.00 per share (the "Milestone Payment"), in cash, upon the achievement of a specified milestone by December 31, 2033. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.07 · Expires 2032-11-03 | Direct | 0 |
Reported balance
After 2023-02-24 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-02-24 · Disposition to issuer · Disposed 77,615 · Balance 0 F3: At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option with an exercise price equal to or greater than the Cash Amount was accelerated and became fully vested and exercisable and automatically converted into the right to receive, upon the occurrence of the Milestone Payment Date (as defined in the CVR Agreement), an amount in cash equal to the product of (a) the total number of Shares subject to such option immediately prior to the effective time of the merger multiplied by (b) the amount, if any, by which (1) the Cash Amount plus the Milestone Payment exceeds (2) the exercise price payable per Share under such option. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of January 8, 2023, by and among CinCor Pharma, Inc. (the "Issuer"), AstraZeneca Finance and Holdings Inc. ("Parent") and Cinnamon Acquisition, Inc., a wholly owned subsidiary of Parent ("Purchaser"), on February 24, 2023, Purchaser completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger").
F2: This line item represents restricted stock units ("RSUs") held by the Reporting Person at the effective time of the Merger, pursuant to the Merger Agreement, except as otherwise set forth in the Merger Agreement, each outstanding RSU was accelerated and became fully vested and was cancelled and automatically converted into the right to receive, without interest, (i) cash in an amount equal to (a) the total number of Shares issuable in settlement of such RSU immediately prior to the effective time of the Merger multiplied by (b) $26.00 per share (the "Cash Amount"), and (ii) one contingent value right ("CVR") per Share issuable in settlement of such RSU, representing the right to receive a contingent payment of $10.00 per share (the "Milestone Payment"), in cash, upon the achievement of a specified milestone by December 31, 2033.
F3: At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option with an exercise price equal to or greater than the Cash Amount was accelerated and became fully vested and exercisable and automatically converted into the right to receive, upon the occurrence of the Milestone Payment Date (as defined in the CVR Agreement), an amount in cash equal to the product of (a) the total number of Shares subject to such option immediately prior to the effective time of the merger multiplied by (b) the amount, if any, by which (1) the Cash Amount plus the Milestone Payment exceeds (2) the exercise price payable per Share under such option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2019 Filed Mar 2, 2019 01:18 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 31,000 | $3.80 | $117,800.00 |
DisclosureSEC source: 0001209191-19-015275 · doc4.xml · nonDerivative · entry 3 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| March 01, 2019 Filed Mar 2, 2019 01:18 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 19,000 | $2.95 | $56,050.00 |
DisclosureSEC source: 0001209191-19-015275 · doc4.xml · nonDerivative · entry 2 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| March 01, 2019 Filed Mar 2, 2019 01:18 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 50,000 | $2.19 | $109,500.00 |
DisclosureSEC source: 0001209191-19-015275 · doc4.xml · nonDerivative · entry 1 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 02:31 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001209191-19-012805 · doc4.xml · derivative · entry 3 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Ordinary Shares · 50,000 shares Expires 2027-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 28, 2017. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 02:31 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 50,000 | $18.97 | $948,500.00 |
DisclosureSEC source: 0001209191-19-012805 · doc4.xml · nonDerivative · entry 2 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,551 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| February 22, 2019 Filed Feb 23, 2019 02:31 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 50,000 | $2.95 | $147,500.00 |
DisclosureSEC source: 0001209191-19-012805 · doc4.xml · nonDerivative · entry 1 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| February 15, 2019 Filed Feb 16, 2019 01:16 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 25,000 | $17.58 | $439,525.00 |
DisclosureSEC source: 0001209191-19-010799 · doc4.xml · nonDerivative · entry 1 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,551 F1 · security: The sale transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.36 to $17.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F4 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| February 01, 2019 Filed Feb 2, 2019 01:33 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (Right to Buy) · Derivative | 53,500 | $0.00 Strike: $16.88 | $0.00 |
DisclosureSEC source: 0001209191-19-006637 · doc4.xml · derivative · entry 7 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,500 Underlying: Ordinary Shares · 53,500 shares Expires 2029-02-01 F10 · derivative.exercise_date: On February 1, 2019, the Reporting Person was granted an option to purchase 53,500 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 16 equal quarterly installments starting on May 15, 2019. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 01, 2019 Filed Feb 2, 2019 01:33 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 38,200 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-006637 · doc4.xml · derivative · entry 6 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,200 Underlying: Ordinary Shares · 38,200 shares Expires not disclosed F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F9 · derivative.exercise_date: On February 1, 2019, the Reporting Person was granted 38,200 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2020, January 31, 2021 and January 31, 2022. F4 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:33 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Units · Derivative | 26,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-006637 · doc4.xml · derivative · entry 5 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Ordinary Shares · 26,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F6 · derivative.exercise_date: On February 1, 2018, the Reporting Person was granted 78,000 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020 and January 31, 2021. The first vesting event occurred on January 31, 2019. F4 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:33 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Units · Derivative | 29,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-006637 · doc4.xml · derivative · entry 4 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,000 Underlying: Ordinary Shares · 29,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F3 · derivative.exercise_date: On February 1, 2017, the Reporting Person was granted 87,000 restricted stock units (the "RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2018, January 31, 2019 and January 31, 2020. The second vesting event occurred on January 31, 2019. F4 · derivative.expiration_date: Not applicable. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:33 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 26,935 | $16.94 | $456,278.90 |
DisclosureSEC source: 0001209191-19-006637 · doc4.xml · nonDerivative · entry 3 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,551 F1 · security: There are no market sales of securities reported on this Form 4. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F7 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. F5 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:33 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 26,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-006637 · doc4.xml · nonDerivative · entry 2 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: There are no market sales of securities reported on this Form 4. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F6 · shares: On February 1, 2018, the Reporting Person was granted 78,000 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020 and January 31, 2021. The first vesting event occurred on January 31, 2019. F4 · price: Not applicable. F5 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 31, 2019 Filed Feb 2, 2019 01:33 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 29,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-006637 · doc4.xml · nonDerivative · entry 1 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: There are no market sales of securities reported on this Form 4. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · shares: On February 1, 2017, the Reporting Person was granted 87,000 restricted stock units (the "RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of January 31, 2018, January 31, 2019 and January 31, 2020. The second vesting event occurred on January 31, 2019. F4 · price: Not applicable. F5 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 09, 2019 Filed Jan 12, 2019 01:16 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001209191-19-003497 · doc4.xml · derivative · entry 3 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,000 Underlying: Ordinary Shares · 200,000 shares Expires 2026-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: On July 1, 2016, the Reporting Person was granted an option to purchase 625,000 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The shares subject to this option shall vest as follows: 25% of the total number of underlying shares shall vest on July 1, 2017, and the remaining 75% of the underlying shares shall vest ratably over the subsequent 36 months. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 09, 2019 Filed Jan 12, 2019 01:16 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 200,000 | $15.26 | $3,051,080.00 |
DisclosureSEC source: 0001209191-19-003497 · doc4.xml · nonDerivative · entry 2 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,486 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.25 to $15.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Includes 1,006 shares purchased under the Issuer's 2017 Employee Stock Purchase Plan (the "ESPP") on May 31, 2018, and 1,484 shares purchased under the ESPP on November 30, 2018. F4 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| January 09, 2019 Filed Jan 12, 2019 01:16 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 200,000 | $2.19 | $438,000.00 |
DisclosureSEC source: 0001209191-19-003497 · doc4.xml · nonDerivative · entry 1 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · balance_after: Includes 1,006 shares purchased under the Issuer's 2017 Employee Stock Purchase Plan (the "ESPP") on May 31, 2018, and 1,484 shares purchased under the ESPP on November 30, 2018. F4 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:47 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001209191-18-052384 · doc4.xml · derivative · entry 4 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 475,000 Underlying: Ordinary Shares · 150,000 shares Expires 2026-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: On July 1, 2016, the Reporting Person was granted an option to purchase 625,000 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The shares subject to this option shall vest as follows: 25% of the total number of underlying shares shall vest on July 1, 2017, and the remaining 75% of the underlying shares shall vest ratably over the subsequent 36 months. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:47 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 70,200 | $10.72 | $752,621.22 |
DisclosureSEC source: 0001209191-18-052384 · doc4.xml · nonDerivative · entry 3 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,996 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.54 to $11.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:47 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | SaleOrdinary Shares | 79,800 | $10.15 | $810,129.60 |
DisclosureSEC source: 0001209191-18-052384 · doc4.xml · nonDerivative · entry 2 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,196 F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.54 to $10.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| September 24, 2018 Filed Sep 27, 2018 00:47 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 150,000 | $2.19 | $328,500.00 |
DisclosureSEC source: 0001209191-18-052384 · doc4.xml · nonDerivative · entry 1 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.direct: Please see the section titled "Remarks" below for additional information. Read SEC document |
| February 01, 2018 Filed Feb 3, 2018 01:24 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (Right to Buy) · Derivative | 117,000 | $3.80 Strike: $3.80 | $444,600.00 |
DisclosureSEC source: 0001209191-18-007271 · doc4.xml · derivative · entry 5 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,000 Underlying: Ordinary Shares · 117,000 shares Expires 2028-02-01 F7 · derivative.exercise_date: On February 1, 2018, the Reporting Person was granted an option to purchase 117,000 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month starting on February 28, 2018. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 01, 2018 Filed Feb 3, 2018 01:24 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 78,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007271 · doc4.xml · derivative · entry 4 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,000 Underlying: Ordinary Shares · 78,000 shares Expires not disclosed F5 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F6 · derivative.exercise_date: On February 1, 2018, the Reporting Person was granted 78,000 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan. These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020 and January 31, 2021. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2018 Filed Feb 3, 2018 01:24 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionRestricted Stock Units · Derivative | 29,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007271 · doc4.xml · derivative · entry 3 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,000 Underlying: Ordinary Shares · 29,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On February 1, 2017, the Reporting Person was granted 87,000 restricted stock units (the "RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan. These RSUs vest in three equal installments on each of January 31, 2018, January 31, 2019 and January 31, 2020. The first vesting event occurred on January 31, 2018. F3 · derivative.expiration_date: Not applicable. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| January 31, 2018 Filed Feb 3, 2018 01:24 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Tax withholdingOrdinary Shares | 14,004 | $3.83 | $53,635.32 |
DisclosureSEC source: 0001209191-18-007271 · doc4.xml · nonDerivative · entry 2 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,996 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · kind: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Read SEC document |
| January 31, 2018 Filed Feb 3, 2018 01:24 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | Exercise / conversionOrdinary Shares | 29,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-007271 · doc4.xml · nonDerivative · entry 1 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · shares: On February 1, 2017, the Reporting Person was granted 87,000 restricted stock units (the "RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan. These RSUs vest in three equal installments on each of January 31, 2018, January 31, 2019 and January 31, 2020. The first vesting event occurred on January 31, 2018. F3 · price: Not applicable. Read SEC document |
| May 15, 2017 Filed Jul 3, 2017 23:19 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantRestricted Stock Units · Derivative | 87,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-042900 · doc4.xml · derivative · entry 1 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,000 Underlying: Ordinary Shares · 87,000 shares Expires not disclosed F1 · security: Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. F2 · derivative.exercise_date: On February 1, 2017, the Reporting Person was granted 87,000 restricted stock units (the "RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs were subject to the approval by the Company's shareholders of an amendment to the Plan, which amendment was approved on May 15, 2017, and were previously disclosed in the Company's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 21, 2017. These RSUs vest in three equal installments on each of January 31, 2018, January 31, 2019 and January 31, 2020. F3 · derivative.expiration_date: Not applicable. F4 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 22:03 UTC | AMARIN CORP PLC\UK AMRN · Entity 5970 | GrantStock Option (right to buy) · Derivative | 133,000 | $2.95 Strike: $2.95 | $392,350.00 |
DisclosureSEC source: 0001209191-17-007156 · doc4.xml · derivative · entry 1 Kalb Michael Wayne · CIK 0001678248 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,000 Underlying: Ordinary Shares · 133,000 shares Expires 2027-01-31 F1 · derivative.exercise_date: On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month starting on February 28, 2017. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.